Lamotrigine Therapy in Neuronal Lipofuscinosis
Lamotrigine (LTG) long-term anticonvulsant therapy was evaluated in 29 patients, aged 6-28 years (mean, 14 years), with juvenile neuronal ceroid lipofuscinosis (JNCL), followed for 1-6 years (mean, 3 years) at the Hospital for Children and Adolescents, University of Helsinki, Finland.
Sábháilte in:
Príomhchruthaitheoir: | J Gordon Millichap (Údar) |
---|---|
Formáid: | LEABHAR |
Foilsithe / Cruthaithe: |
Pediatric Neurology Briefs Publishers,
1999-08-01T00:00:00Z.
|
Ábhair: | |
Rochtain ar líne: | Connect to this object online. |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Míreanna comhchosúla
-
Epilepsy in Juvenile Neuronal Ceroid Lipofuscinosis
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (2000) -
Subdural Effusion and Infantile Neuronal Ceroid Lipofuscinosis
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (2010) -
EEG in Late Infantile Neuronal Ceroid Lipofuscinosis
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (2001) -
Spino-Cerebellar Degeneration and Ceroid Lipofuscinosis
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (1988) -
Neuronal ceroid lipofuscinosis and Bardet-Biedl syndrome in patient with retinitis pigmentosa
de réir: José D. Santotoribio, et al.
Foilsithe / Cruthaithe: (2021)